JOHN MONAHAN

Profile

First Name

: JOHN

Middle Name

:

Last Name

: MONAHAN

Related Companies
Titles
Company Name
Related People
DIRECTOR
HEAT BIOLOGICS, INC.
PAUL BELSKY, PAUL MARC BELSKY, VADIM DEYEV, JENNIFER LYNN HARRIS, JEFFREY HUTCHINS, SCOTT KATZMAN, MICHAEL KHARITONOV, JOHN JAMES MONAHAN, WILLIAM OSTRANDER, JOHN PRENDERGAST, JOHN K.A. PRENDERGAST, ANN ROSAR, SANDRA LETA SILBERMAN, EDWARD SMITH, EDWARD BYRON SMITH, III, TAFFY WILLIAMS, JEFF WOLF, JEFFREY WOLF, JEFFREY ALAN WOLF
EXECUTIVE OFFICER
HEALTHPRIZE TECHNOLOGIES, LLC
ROBERT DAHL, MARK DISALVO, HENSLEY EVANS, KATRINA FIRLIK, MICHAEL A GRIFFITH, KEVIN JONES, JAMES JORASCH, ROBERT KAMERSCHEN, RUBEN KING-SHAW JR., THOMAS KOTTLER, DAWN OWENS, DOUGLAS POLING, DAVID RECTOR, DIETER WEINAND
DIRECTOR
SYNTHETIC BIOLOGICS, INC.
C. EVAN BALLANTYNE, STEVE KANZER, STEVE H. KANZER, JEFFREY KRAWS, JEFFREY J. KRAWS, JEFFREY RILEY, STEVEN SHALLCROSS, STEVEN A SHALLCROSS, STEVEN A. SHALLCROSS, JOSEPH SLIMAN, SCOTT TARRIFF, SCOTT L. TARRIFF, JEFFREY WOLF, JEFFREY A. WOLF
DIRECTOR
SCORPIUS HOLDINGS, INC.
PAUL BELSKY, PAUL MARC BELSKY, VADIM DEYEV, JENNIFER LYNN HARRIS, JEFFREY HUTCHINS, SCOTT KATZMAN, MICHAEL KHARITONOV, JOHN JAMES MONAHAN, WILLIAM OSTRANDER, JOHN PRENDERGAST, JOHN K.A. PRENDERGAST, ANN ROSAR, SANDRA LETA SILBERMAN, EDWARD SMITH, EDWARD BYRON SMITH, III, TAFFY WILLIAMS, JEFF WOLF, JEFFREY WOLF, JEFFREY ALAN WOLF
DIRECTOR
THERIVA BIOLOGICS, INC.
C. EVAN BALLANTYNE, STEVE KANZER, STEVE H. KANZER, JEFFREY KRAWS, JEFFREY J. KRAWS, JEFFREY RILEY, STEVEN SHALLCROSS, STEVEN A SHALLCROSS, STEVEN A. SHALLCROSS, JOSEPH SLIMAN, SCOTT TARRIFF, SCOTT L. TARRIFF, JEFFREY WOLF, JEFFREY A. WOLF
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-10-17 
2025-02-18
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-02-12 
2025-02-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-01-30 
2024-12-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2024-12-06 
2022-08-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-07-29 
2022-03-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-10 
2020-12-14
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-10-31 
2017-05-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-04-28 
2011-12-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-20 
2009-11-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-03